Diasome Pharmaceuticals Inc
Diasome Pharmaceuticals Inc, based in Cleveland, OH, is at the forefront of developing innovative therapies for metabolic disorders, particularly focusing on diabetes management. Their proprietary Hepatocyte Directed Vesicle (HDV) platform targets hepatocyte cells to enhance glucose and lipid control, merging advanced drug delivery systems with pharmaceutical treatments.
The company is pioneering the understanding of hepatocyte cells' role in whole-body metabolism, aiming to create medications that significantly improve human health. With a diverse pipeline that includes both oral and injectable therapies, Diasome is committed to addressing the underlying deficiencies contributing to metabolic diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
